|
It was reported that the previously capped pace/sense portion of the right ventricular (rv) lead eroded through the skin and was the source of infection.The lead and lead cap were explanted and replaced with a previously capped rv pace/sense lead plugged into the pace/sense port of the cardiac resynchronization therapy defibrillator (crt-d).Detections were deactivated, the high voltage port was plugged, and the system remains in use for pacing support.No further patient complications have been reported as a result of this event.
|
|
Continuation of d10: 5054-52 lead; implanted: (b)(6) 2001, 5554-45 lead; implanted: (b)(6) 2001, dtpa2q1 crt-d; implanted (b)(6) 2023.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|